Polarean Imaging Share Discussion Threads

[kingston78] 16/7/2024 08:43

POLX is on an upward move. It is going to break the 2 p level soon. The low placing price was forced upon the company due to market conditions. In better times it could have raised money at 3 or 4 p when its share price was at 5 p, which dropped like a stone.

It has a world-first device used in hospitals in the US. All it needs is to expand the sales network in the US and other countries. Management should capitalise on the company's invention quickly.

[bones698] 12/7/2024 22:25

From the resukts losses 11.8im I think you will find that's nearer to the truth than their estimated runway which will factor in deals that have not materialised so far. If they don't come it will be sooner. Nice try but as usual misguided. Took you off filter to read your comment but nothing new so back on.

Should have stayed in Gdr far better prospects than here. Of the two that is far better option imo and it's showing now. As usual u sold far to early there and stuck with this dog

[john henry] 12/7/2024 18:42

Not quite Boney

Successfully raised gross proceeds of US$12.6 million (£9.9 million), including participation of existing strategic partners NUKEM Isotopes GmbH and Bracco Imaging S.p.A., and certain Directors and management of the Company demonstrating their continued support and extending cash runway until at least Q1 2026

[bones698] 12/7/2024 18:38

Should be back at 1.3p soon no deals announced for months. High cash burn time running out. Great product but seem unable to sell it in the amount needed to get revenues moving in upward. Cash will run out long before that happens. No cost cutting taking place, they will blow the lot far too quickly with nearly 1m a month cash burn

[jrlomax] 12/7/2024 15:37

The board need to pull their finger out.

[moontheloon] 12/7/2024 14:58

Seem to be balancing letting people exit with some buying

[moontheloon] 12/7/2024 08:26

Think case of stagnation till next deal news whenever that occurs.

[john henry] 12/7/2024 08:16

The selling its slowing however theres very little buying.

[moontheloon] 12/7/2024 07:47

Does seem to be a pattern of lower lows since the spike. Without news my gut reaction says downwards till news

[moontheloon] 12/7/2024 07:45

Depends how many 1p shares get bored and sell for 58% profit

[moontheloon] 12/7/2024 07:44

Where to today guys without news again?

[john henry] 11/7/2024 14:27

Moon i should imagine the trialist where happy having xenon for nowt.

[moontheloon] 11/7/2024 13:37

Expected some of these trialists to have changed sooner than this. If the trialists in fact don't convert then that's bad news. Hopefully some in the process

[moontheloon] 11/7/2024 13:35

10/10 for institutions and directors who got the 1p however

[john henry] 11/7/2024 13:32

There's know doubt POLX are in the right space at the right time. Question is can the present management execute. Jury is out. Up till now 10/10 for development and FDA approval. 3/10 for commercialisation progress. Financials Placing etc big fat Zero.

[moontheloon] 11/7/2024 13:02

Me included

[john henry] 11/7/2024 12:59

Agree was looking promising however shed load of open offer sellers stepped up

[goldbutler] 11/7/2024 12:59

' Near automatic approval is the phrase used



From 2024, [the MHRA] will move to a different [regulatory] model, which will allow rapid, often near-automatic sign-off for medicines and technologies already approved by trusted regulators in other parts of the world such as the United States, Europe and Japan. At the same time, it will set up a swift new approval process for the most cutting-edge medicines and devices to ensure that the UK becomes a global centre for their development.

If you can quote 'pre-approved' source - do that

[moontheloon] 11/7/2024 12:57

Down we go fun's over

[moontheloon] 11/7/2024 12:31

We are approved in the uk as they pre approve anything previously approved by fda

[goldbutler] 11/7/2024 12:20

Responding to Streeting’s comments, Peter Ellingworth, chief executive of the British Association of British HealthTech Industries, told Digital Health News

that “urgent steps are required” to be able to lead a revolution in MedTech and ensure the UK remains a favourable destination for the sector.

“We must accelerate the delivery of international recognition for product approvals, ensuring the Regulator is appropriately resourced to do this alongside developing sovereign arrangements which are synonymous with innovation and early access.

“We must also ensure that the NHS is fully resourced to maximise the adoption and spread of innovative technologies, both those that are here now but underutilised, and those that are emerging,” Ellingworth said.


There is no good reason not to seek approval in the UK
Board changes are needed at Polarean

[goldbutler] 11/7/2024 12:11

Wes Streeting on MRIS and new tech for UK - 09 July 2024

“If you look at some of Labour’s first steps in our manifesto, doubling the number of CT and MRI scanners and not just more scanners, but AI-enabled scanners, those are massive productivity gains.

“Those are massive improvements for patient experience in terms of how many people we can get through and how quickly – they’re massive improvements in the quality of diagnostics”.



Polarean CEO & Board of Directors really have no reason not to seek UK approval
No excuses acceptable

[moontheloon] 11/7/2024 10:31

Yeah me too on less than 500k